Picture of SK Biopharmaceuticals Co logo

326030 SK Biopharmaceuticals Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: SK Biopharmaceuticals Co Q1 Preliminary Operating Profit 89.8 Billion Won Up 249.7% Y/Y

May 7 (Reuters) - SK Biopharmaceuticals Co Ltd 326030.KS:

SK BIOPHARMACEUTICALS CO: Q1 PRELIMINARY OPERATING PROFIT 89.8 BILLION WON UP 249.7% Y/Y

Source text: [ID:]

Further company coverage: 326030.KS

Recent news on SK Biopharmaceuticals Co

See all news